Stay updated on Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe revision label on the page updates from v3.6.6 to v3.7.0. This marks a newer version of the page without providing details about content changes.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page now shows Revision: v3.6.6, updating from Revision: v3.6.5 to reflect a newer system release.SummaryDifference0.0%

- Check28 days agoChange DetectedThe NIH funding line now includes the year 2017 (U.S. NIH Grant/Contract) in the study's identifiers. This clarifies the funding source associated with the trial.SummaryDifference0.0%

- Check42 days agoChange DetectedRevision: v3.6.5 was added to the page’s revision history and Revision: v3.6.4 was removed, updating the version information reflected on the page.SummaryDifference0.0%

- Check49 days agoChange DetectedThe Study Documents section now omits several PDFs and references (CSR synopsis, SAP, CSP, IPD Sharing information, and related disclosures). This change removes access to key study documentation and data-sharing commitments, altering how users can review the trial's protocol and results materials.SummaryDifference17%

- Check64 days agoChange DetectedThe page's revision tag was updated to v3.6.4 from v3.6.3, indicating a minor metadata update to the study record. This does not change any study details or user-facing content presented on the page.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo + Maintenance in Advanced Ovarian Cancer Clinical Trial page.